A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells
Table 2
Blood glucose data from electronic diaries and gestational weight gain.
GDM 1 ()
GDM2 ()
Control ()
control-GDM1
control-GDM2
GDM1-GDM2
Gestational weight gain, kg
9.9 ± 4.9
9.5 ± 5.9
15.2 ± 7.8
0.006
0.023
0.023
0.970
BG average, mmol/L
5.6 ± 0.3
5.9 ± 0.4
6.0 ± 0.5
0.004
0.110
0.893
0.005
Fasting BG, mmol/L
4.7 ± 0.4
4.8 ± 0.3
4.7 ± 0.3
0.499
0.835
0.421
0.735
1 h postprandial BG, mmol/L
5.9 ± 0.3
6.4 ± 0.5
6.5 ± 0.7
0.002
0.088
0.818
0.002
Number of BG measurements
140 ± 78
147 ± 60
42 ± 21
0.001
<0.001
<0.001
0.946
% () treated with insulin
40% (8)
29% (6)
N/A
0.495
Note: derived from electronic diaries filled in by participants ( GDM1 = 19, GDM2 = 20, control = 8) during the study period. BG: blood glucose; N/A: nonapplicable.
